We fuel innovation across technology, healthcare, distribution, and beauty.
ORANGEinfinity Holdings is an international investment business with investments in the Technology, Healthcare, Distribution and Beauty product sectors.
Chief Executive Officer
Executive Director
ORANGEinfinity Holdings is a Sydney-based international investment firm with a strategic focus on technology, healthcare, distribution, and beauty. The company operates through four core divisions: OI Health, OI Technology, OI Retail, and OI Distribution. These units are supported by OI Treasury Services, which manages group liquidity and financial operations. The board is led by Chief Executive Officer and Managing Director Darren Dye, alongside Executive Director Ms Xing Mao.
Founded in 2017 by Ms Xing Mao, ORANGEinfinity was established as a forward-looking investment vehicle to identify high-growth opportunities across diverse sectors. In 2023, the company expanded significantly with the acquisition of AMA Medical Products—one of Australia’s most trusted medical suppliers. ORANGEinfinity continues to pursue growth across the UK, Southeast Asia, and the technology sector.
In September 2023, Darren Dye was appointed CEO following his successful tenure as CEO of the Pharmacy Alliance Group, Australia’s largest independent pharmacy network.
As of 2023, ORANGEinfinity’s four main business units—OI Health, OI Technology, OI Retail, and OI Distribution—drive its sector strategy. OI Distribution includes the AMA Medical Products business and oversees international logistics and wholesale operations. Group-wide financial management is handled by OI Treasury and Technology Services, ensuring efficient capital allocation and sustained growth.